tiprankstipranks

Analyst Profile

Followed by 305 followers
.
Terence Flynn

Terence Flynn

Morgan Stanley
Wall Street Analyst
#606 out of 7,962 Wall Street Analysts
#1,207 out of 22,231 experts

Success Rate

64%
76 out of 119 transactions made a profit

Average Return

+12.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Terence Flynn's trades since 2009 and holding each position for 1 Year would result in 63.87% of your transactions generating a profit, with an average return of 12.1% per rating.

Stock Rating Distribution

247Ratings
46.56% Buy
42.91% Hold
10.53% Sell
Distribution of Terence Flynn's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
InterMune Inc
(ITMN)
Rating:Buy
Date:May 01, 2009 - May 01, 2010
Return:+238.70%
The most profitable rating made by Terence Flynn

Terence Flynn's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ARNA
Arena Pharma
Sep 18, 2009
Hold
Reiterated
1Ratings
0.00%
ONXX
Onyx Pharma
Jan 13, 2012
Buy
Reiterated
1Ratings
100%
+91.10%
CBST
Cubist Pharma
Jul 31, 2013
Hold
Downgraded
1Ratings
0.00%
VPHM
Viropharma
Sep 18, 2013
Hold
Reiterated
1Ratings
0.00%
ARIA
Ariad
Feb 27, 2014
Hold
Reiterated
3Ratings
0.00%
ITMN
InterMune
Aug 14, 2014
Hold
Downgraded
5Ratings
100%
+108.80%
Seres Therapeutics
Jul 21, 2015
Hold
Initiated
$36.00
(516.44% Upside)
1Ratings
0.00%
Clovis Oncology
Nov 18, 2015
Hold
Downgraded
$23.00
(2090.48% Upside)
5Ratings
0%
-68.60%
Atara Biotherapeutics
Nov 18, 2015
Hold
Assigned
$38.00
(1020.94% Upside)
1Ratings
0.00%
DMTX
Dimension Therapeutics Inc
Dec 04, 2015
Buy
Assigned
2Ratings
0%
-63.70%
List of latest recommendations made by Terence Flynn. Click to expand and see Terence Flynn's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >